| Aktsiad | 258,174 mld. | - | KoAct | 0 | Tervishoid | | 3.8.2023 | 17 589,14 | 5,52 | 37,04 |
| Aktsiad | 219,816 mld. | - | Tiger ETF | 0,40 | Tervishoid | KRX Healthcare - KRW | 15.7.2011 | 42 373,43 | 4,52 | 48,76 |
| Aktsiad | 197,949 mld. | - | Tiger ETF | 0,40 | Tervishoid | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 6.10.2020 | 7924,10 | 5,51 | 76,05 |
| Aktsiad | 170,177 mld. | - | KODEX | 0,45 | Tervishoid | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 10 242,07 | 3,88 | 37,93 |
| Aktsiad | 89,843 mld. | - | Tiger ETF | 0,49 | Tervishoid | Solactive China Biotech Index | 3.12.2020 | 9867,65 | 4,89 | 38,29 |
| Aktsiad | 81,932 mld. | - | KODEX | 0,09 | Tervishoid | KRX Healthcare - KRW | 28.3.2017 | 19 171,41 | 4,53 | 48,83 |
| Aktsiad | 65,818 mld. | - | KODEX | 0,45 | Tervishoid | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 10 234,98 | 7,66 | 17,31 |
| Aktsiad | 65,027 mld. | - | Tiger ETF | 0,30 | Tervishoid | NASDAQ Biotechnology Index | 26.8.2014 | 25 730,83 | 4,50 | 18,42 |
| Aktsiad | 62,926 mld. | - | Tiger ETF | 0,45 | Tervishoid | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 9457,95 | 10,04 | 20,45 |
| Aktsiad | 47,562 mld. | - | KODEX | 0,25 | Tervishoid | S&P Health Care Select Sector | 21.3.2023 | 12 220,11 | 4,78 | 22,13 |
| Aktsiad | 37,119 mld. | - | Tiger ETF | 0,40 | Tervishoid | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 20 020,08 | 2,89 | 34,38 |
| Aktsiad | 36,139 mld. | 12,843 mln. | SPDR | 0,08 | Tervishoid | S&P Health Care Select Sector | 16.12.1998 | 142,09 | 4,83 | 22,27 |
| Aktsiad | 31,209 mld. | - | Tiger ETF | 0,40 | Tervishoid | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 14.12.2016 | 16 357,81 | 8,50 | 59,10 |
| Aktsiad | 26,382 mld. | - | Hwabao | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,40 | 2,89 | 27,06 |
| Aktsiad | 24,607 mld. | - | Tiger ETF | 0 | Tervishoid | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 29.6.2016 | 23 297,64 | 0 | 0 |
| Aktsiad | 19,073 mld. | - | KB RISE | 0 | Tervishoid | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 13 336,89 | 9,56 | 68,04 |
| Aktsiad | 18,658 mld. | - | E Fund | 0 | Tervishoid | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,45 | 3,43 | 26,91 |
| Aktsiad | 17,091 mld. | - | KODEX | 0,25 | Tervishoid | S&P Biotechnology Select Industry | 31.10.2013 | 30 473,58 | 0 | 0 |
| Aktsiad | 16,048 mld. | 276 938,1 | Vanguard | 0,09 | Tervishoid | MSCI US IMI 25/50 Health Care | 26.1.2004 | 264,68 | 4,41 | 21,12 |
| Aktsiad | 11,12 mld. | - | NH-Amundi | 0 | Tervishoid | | 26.11.2024 | 13 007,68 | 4,88 | 36,08 |
| Aktsiad | 9,71 mld. | - | KB RISE | 0 | Tervishoid | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 14 797,12 | 4,39 | 41,47 |
| Aktsiad | 7,811 mld. | - | ACE | 0,45 | Tervishoid | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 11 339,55 | 0 | 0 |
| Aktsiad | 7,596 mld. | - | ACE | 0,30 | Tervishoid | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 11 014,50 | 0 | 0 |
| Aktsiad | 7,436 mld. | - | Bosera | 0,65 | Tervishoid | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,72 | 1,92 | 12,80 |
| Aktsiad | 7,272 mld. | - | Tiger ETF | 0,50 | Tervishoid | FnGuide Medical Device Index - KRX - Benchmark TR Net | 7.11.2018 | 18 351,33 | 2,60 | 18,32 |
| Aktsiad | 6,989 mld. | - | KoAct | 0,50 | Tervishoid | | 3.9.2024 | 10 116,86 | 3,91 | 15,51 |
| Aktsiad | 6,634 mld. | - | Invesco | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,93 | 2,24 | 0 |
| Aktsiad | 6,348 mld. | 1,773 mln. | iShares | 0,44 | Tervishoid | NYSE Biotechnology (TR) | 5.2.2001 | 149,97 | 4,97 | 19,75 |
| Aktsiad | 6,339 mld. | 9,022 mln. | SPDR | 0,35 | Tervishoid | S&P Biotechnology Select Industry | 31.1.2006 | 104,95 | 4,59 | 0 |
| Aktsiad | 6,103 mld. | - | Kiwoom | 0,49 | Tervishoid | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 11 045,57 | 0 | 0 |
| Aktsiad | 5,954 mld. | - | ChinaAMC | 0,65 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,94 | 2,08 | 13,72 |
| Aktsiad | 5,784 mld. | - | NEXT FUNDS | 0,32 | Tervishoid | | 21.3.2008 | 27 777,36 | 1,77 | 22,28 |
| Aktsiad | 5,441 mld. | - | Nippon | 0,19 | Tervishoid | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,86 | 31,62 |
| Aktsiad | 5,311 mld. | - | ICBC | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,52 | 0 | 0 |
| Aktsiad | 4,988 mld. | - | KB RISE | 0,35 | Tervishoid | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 9219,93 | 8,66 | 21,73 |
| Aktsiad | 4,915 mld. | - | Tiger ETF | 0,40 | Tervishoid | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12 065,00 | 0 | 0 |
| Aktsiad | 4,628 mld. | - | Maxwealth | 0,60 | Tervishoid | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,55 | 2,58 | 29,11 |
| Aktsiad | 4,526 mld. | - | Kiwoom | 0,49 | Tervishoid | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 10 085,59 | 4,36 | 17,59 |
| Aktsiad | 4,146 mld. | 897 902,6 | iShares | 0,38 | Tervishoid | DJ US Select / Medical Equipment | 1.5.2006 | 58,79 | 4,21 | 27,85 |
| Aktsiad | 4,053 mld. | 170 584,1 | iShares | 0,40 | Tervishoid | S&P Global 1200 / Health Care -SEC | 13.11.2001 | 90,70 | 4,40 | 21,86 |
| Aktsiad | 3,665 mld. | - | Fullgoal | 0,60 | Tervishoid | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,64 | 0 | 0 |
| Aktsiad | 3,347 mld. | - | Guotai | 0,60 | Tervishoid | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 1,20 | 0 | 0 |
| Aktsiad | 3,083 mld. | - | Xtrackers | 0,25 | Tervishoid | MSCI World Index / Health Care -SEC | 22.11.2010 | 55,19 | 4,51 | 21,82 |
| Aktsiad | 2,902 mld. | 558 791,8 | iShares | 0,38 | Tervishoid | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 59,88 | 4,81 | 21,82 |
| Aktsiad | 2,795 mld. | - | E Fund | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,58 | 0 | 0 |
| Aktsiad | 2,735 mld. | - | NH-Amundi | 0,45 | Tervishoid | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9115,65 | 3,43 | 26,31 |
| Aktsiad | 2,608 mld. | 163 926,8 | Fidelity | 0,08 | Tervishoid | MSCI US IMI 25/50 Health Care | 21.10.2013 | 68,18 | 4,74 | 22,22 |
| Aktsiad | 2,428 mld. | - | iShares | 0,15 | Tervishoid | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 11,34 | 4,84 | 22,30 |
| Aktsiad | 2,319 mld. | - | E Fund | 0,20 | Tervishoid | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,28 | 2,51 | 20,30 |
| Aktsiad | 2,026 mld. | - | Guotai | 0,60 | Tervishoid | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,49 | 2,90 | 27,05 |
| Aktsiad | 1,551 mld. | - | Harvest ETFs | 1,06 | Tervishoid | | 19.11.2014 | 7,43 | 4,58 | 20,72 |
| Aktsiad | 1,537 mld. | - | Ping An | 0,60 | Tervishoid | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,42 | 3,94 | 23,22 |
| Aktsiad | 1,49 mld. | - | Amundi | 0,50 | Tervishoid | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9937,75 | 2,82 | 14,76 |
| Aktsiad | 1,483 mld. | - | ChinaAMC | 0,75 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 16,94 | 4,10 | 28,44 |
| Aktsiad | 1,483 mld. | - | ChinaAMC | 0,75 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 16,94 | 4,10 | 28,44 |
| Aktsiad | 1,457 mld. | - | Cathay | 1,05 | Tervishoid | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 7,43 | 3,36 | 18,58 |
| Aktsiad | 1,398 mld. | - | iShares | 0,46 | Tervishoid | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 140,69 | 0 | 0 |
| Aktsiad | 1,397 mld. | - | iShares | 0,18 | Tervishoid | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 6,81 | 3,99 | 20,14 |
| Aktsiad | 1,306 mld. | - | E Fund | 0,20 | Tervishoid | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,57 | 2,79 | 29,19 |
| Aktsiad | 1,269 mld. | - | CSOP | 1,50 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 4,15 | 4,02 | 28,16 |
| Aktsiad | 1,233 mld. | 449 959,8 | VanEck | 0,36 | Tervishoid | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 92,14 | 4,95 | 19,53 |
| Aktsiad | 1,162 mld. | - | E Fund | 0,20 | Tervishoid | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,46 | 4,44 | 30,07 |
| Aktsiad | 1,131 mld. | 12 211,73 | First Trust | 0,54 | Tervishoid | NYSE Arca Biotechnology Index | 19.6.2006 | 182,68 | 3,69 | 21,57 |
| Aktsiad | 1,025 mld. | - | Harvest | 0,60 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 1,01 | 0 | 0 |
| Aktsiad | 1,005 mld. | - | iShares | 0,40 | Tervishoid | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 8,29 | 3,88 | 22,62 |
| Aktsiad | 1,005 mld. | - | iShares | 0,40 | Tervishoid | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 8,29 | 3,88 | 22,62 |
| Aktsiad | 998,217 mln. | - | Wanjia | 0 | Tervishoid | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,86 | 2,24 | 0 |
| Aktsiad | 920,294 mln. | 22 843,96 | First Trust | 0,62 | Tervishoid | StrataQuant Health Care Index | 8.5.2007 | 109,66 | 2,59 | 15,62 |
| Aktsiad | 825,441 mln. | 454 365,3 | iShares | 0,38 | Tervishoid | DJ US Select / Health Care Providers | 1.5.2006 | 49,67 | 2,42 | 17,06 |
| Aktsiad | 815,601 mln. | 1,081 mln. | Direxion | 0,93 | Tervishoid | S&P Biotechnology Select Industry | 28.5.2015 | 107,17 | 0 | 0 |
| Aktsiad | 775,071 mln. | - | E Fund | 0,20 | Tervishoid | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,76 | 3,14 | 28,66 |
| Aktsiad | 773,909 mln. | - | Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 146,98 | 3,34 | 24,14 |
| Aktsiad | 773,909 mln. | - | Amundi | 0,30 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 146,98 | 3,34 | 24,14 |
| Aktsiad | 727,663 mln. | - | Global X | 0,68 | Tervishoid | Solactive China Biotech Index | 25.7.2019 | 79,95 | 5,00 | 40,94 |
| Aktsiad | 727,663 mln. | - | Global X | 0,68 | Tervishoid | Solactive China Biotech Index | 25.7.2019 | 79,95 | 5,00 | 40,94 |
| Aktsiad | 721,924 mln. | - | Xtrackers | 0,12 | Tervishoid | MSCI USA / Health Care -SEC | 12.9.2017 | 58,64 | 4,98 | 22,25 |
| Aktsiad | 721,924 mln. | - | Xtrackers | 0,12 | Tervishoid | MSCI USA / Health Care -SEC | 12.9.2017 | 58,64 | 4,98 | 22,25 |
| Aktsiad | 718,272 mln. | 79 530,78 | Invesco | 0,40 | Tervishoid | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 29,56 | 2,98 | 20,44 |
| Aktsiad | 716,916 mln. | - | Amundi | 0,30 | Tervishoid | MSCI World Index / Health Care -SEC | 19.8.2010 | 457,53 | 7,68 | 29,88 |
| Aktsiad | 713,603 mln. | - | iShares | 0,46 | Tervishoid | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 109,77 | 3,87 | 20,04 |
| Aktsiad | 698,543 mln. | - | SPDR | 0,18 | Tervishoid | MSCI Europe Health Care Index - EUR | 5.12.2014 | 216,15 | 3,99 | 20,14 |
| Aktsiad | 685,319 mln. | - | SOL | 0,45 | Tervishoid | FnGuide Medical Device Director Index - KRW - Benchmark Price Return | 22.8.2023 | 10 936,55 | 2,66 | 19,70 |
| Aktsiad | 660,484 mln. | - | iShares | 0,35 | Tervishoid | NASDAQ Biotechnology Index | 19.10.2017 | 7,37 | 0 | 0 |
| Aktsiad | 608,42 mln. | 38 482,82 | iShares | 0,38 | Tervishoid | DJ US Select / Pharmaceutical | 1.5.2006 | 73,99 | 3,83 | 20,25 |
| Aktsiad | 536,763 mln. | - | SPDR | 0,30 | Tervishoid | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 29.4.2016 | 62,80 | 5,08 | 25,68 |
| Aktsiad | 532,707 mln. | - | China Southern | 0,65 | Tervishoid | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,31 | 2,06 | 13,71 |
| Aktsiad | 503,633 mln. | - | iShares | 0,66 | Tervishoid | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 66,46 | 0 | 0 |
| Aktsiad | 494,244 mln. | - | Global X | 0,59 | Tervishoid | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1658,22 | 2,29 | 21,64 |
| Aktsiad | 477,663 mln. | - | Guotai | 0,60 | Tervishoid | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 1,00 | 0 | 0 |
| Aktsiad | 470,965 mln. | - | Fullgoal | 0,60 | Tervishoid | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 1,07 | 0 | 0 |
| Aktsiad | 448,576 mln. | - | SPDR | 0,15 | Tervishoid | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 43,75 | 4,84 | 22,31 |
| Aktsiad | 445,339 mln. | - | Guotai | 0,60 | Tervishoid | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,85 | 2,52 | 20,87 |
| Aktsiad | 443,329 mln. | - | iShares | 0,18 | Tervishoid | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 17.10.2019 | 7,33 | 4,16 | 22,04 |
| Aktsiad | 443,329 mln. | - | iShares | 0,18 | Tervishoid | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 17.10.2019 | 7,33 | 4,16 | 22,04 |
| Aktsiad | 410,373 mln. | - | Cathay | 0,41 | Tervishoid | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 30,39 | 0 | 0 |
| Aktsiad | 387,656 mln. | - | Invesco | 0,40 | Tervishoid | NASDAQ / Biotechnology | 6.11.2014 | 53,36 | 4,55 | 18,64 |
| Aktsiad | 360,217 mln. | - | Invesco | 0,14 | Tervishoid | S&P Select Sector Capped 20% Health Care Index | 16.12.2009 | 708,47 | 4,44 | 20,75 |
| Aktsiad | 352,498 mln. | 5617,222 | VanEck | 0,35 | Tervishoid | MVIS US Listed Biotech 25 | 20.12.2011 | 172,13 | 4,39 | 20,37 |
| Aktsiad | 348,094 mln. | - | China Southern | 0,20 | Tervishoid | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,74 | 2,45 | 22,16 |
| Aktsiad | 328,546 mln. | - | Maxwealth | 0,60 | Tervishoid | CSI Hong Kong Stock Connect Healthcare Index - CNY - Benchmark TR Net | 2.4.2025 | 1,68 | 0 | 0 |